Jefferies Sees Cameco (CCJ) and BWXT as Winners in the Nuclear Boom
Jefferies initiated coverage of Cameco (CCJ) and BWXT (BWXT) with 'Buy' ratings, setting price targets of $138 and $181 respectively, citing strong long-term prospects in nuclear energy. CCJ, a major uranium producer, and BWXT, a nuclear reactor provider, are positioned to benefit from global and U.S. initiatives to expand nuclear capacity. Both companies face risks, including uranium price volatility for CCJ and execution challenges for BWXT.
How this was made

The 30-second read
Why it matters
Analyst initiation and target upgrades provide fresh, material information that can influence trading decisions for CCJ and BWXT.
Market read
First‑time analyst coverage of two nuclear‑energy firms introduces actionable upside potential for traders.
What to watch
Execution risk on the Army micro‑reactor program could delay BWXT's revenue upside.
Background
Jefferies turned bullish on the nuclear sector, initiating coverage of two U.S. listed companies with new price targets.
Ticker impact
Jefferies initiated coverage of Cameco (CCJ) with a Buy rating and a $138 price target, implying over 31% upside.
Potential upside of 30%+ if target is reached; short-term rally likely.
Coverage initiation is a primary catalyst; Jefferies' bullish stance may attract institutional interest.
Jefferies initiated coverage of BWX Technologies (BWXT) with a Buy rating and a $181 price target, implying about 13% upside.
Expect modest upside of 10‑15% as investors price in the new target.
Analyst coverage combined with a disclosed $2.2 bn Army contract provides a concrete growth catalyst.
Market effects
The bullish stance may lift other uranium miners and nuclear‑reactor suppliers as the sector gains visibility.
U.S. nuclear‑technology stocks could see increased demand from investors tracking policy‑driven growth.
International nuclear‑energy players may benefit from heightened investor focus on the global nuclear build‑out.
Counterpoint
If uranium prices remain weak, Cameco's upside could be limited despite the coverage.
Key entities
- companyCameco Corporation
Uranium miner with a new Buy rating and $138 price target.
- companyBWX Technologies, Inc.
Nuclear reactor supplier with a new Buy rating and $181 price target.



